A cost-effectiveness analysis of universal genetic testing for common hereditary cancer mutations in women compared with family-history based testing

      Objectives: Identifying patients who would benefit from hereditary cancer genetic testing by family history alone can miss a significant portion of both BRCA and Lynch mutation carriers. The purpose of this study is to determine whether population-based testing with a common hereditary cancer panel in all women regardless of family history is a cost-effective cancer prevention strategy.
      To read this article in full you will need to make a payment


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect